Tabula Rasa’s Jacques Turgeon, BPharm, PhD, Chief Scientific Officer and CEO, TRHC Precision Pharmacotherapy Research and Development Institute is featured in The Hill. Turgeon discusses how uncoordinated prescription regimens can lead to decreases in drug efficacy and greater risk of adverse effects, such as falls, emergency room visits, hospitalization, and even death.
Share this:Why we need a modern act to prevent harm from medications
In The News | Apr 06, 2022